1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Feasibility: new trials by email Literature Review of Feasibility trials Research Report on Feasibility
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry? liraglutide 3 mg (Saxenda®) once-daily - Mental Disorder, Metabolic Disturbance | Phase 4 | Completed | Anders Fink-Jensen, MD, DMSci | 24 | 2021-07-01 | 2023-08-08 |
Mental Disorders (1) · Obesity (1) · Overweight (1)
Body Weight (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Liraglutide (1)
Anders Fink-Jensen, MD, DMSci (1)
Denmark (1)